Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Evaluation of the humoral response during ocrelizumab therapy in multiple sclerosis - an observational study.
Hippocampal teneurin-4 knockdown promotes depression-like behavioral phenotypes by disrupting oligodendrocyte differentiation in mice.
Lead (Pb) exposure results in cell type specific changes in the mouse retina and optic nerve.
Natalizumab for pediatric multiple sclerosis: a systematic review and meta-analysis.
Diagnostic yield of the 2022 optic neuritis criteria and an antibody-stratified adjunct in an antibody-predominant Chinese clinical sample.
The potential roles of nicotinic acetylcholine receptors in the pathogenesis of multiple sclerosis: A comprehensive review.
Statin Therapy Protects White Matter in Cerebral Small Vessel Disease Independent of Lipid-Lowering: Biomarker and Neuroimaging Evidence.
Trends and disparities in the burden of autoimmune diseases in China and globally: A comparative analysis based on the Global Burden of Disease Study 2021.
Which medication improves fatigue in patients with multiple sclerosis (MS)?: a systematic review and network meta-analysis.
The Effect of Ocrelizumab on Anti-JC Virus Antibody Index.
Loss of disrupts myelination in a zebrafish model of -associated disease.
Associations between bullous pemphigoid and comorbidities: A Swedish nationwide cohort study of 5,738 patients.
Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study.
Spinal H-Sign in Syphilitic Myelitis Mimicking MOGAD.
The Translational Potential of Oligodendrogenesis-Based Therapies for the Recovery of Neurological Diseases.
Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update.
Exploratory Analysis of Neuroimaging and Molecular Findings in a Cohort of Neuronal Ceroid Lipofuscinosis: a Descriptive study.
Diverging trajectories of multiple sclerosis burden in postmenopausal women across East Asia: a comparative analysis of China, Japan, and the Republic of Korea from 1990 to 2050.
Orthography implicitly influences the trustworthiness of onscreen information in the Japanese language.
Socioeconomic status in Behçet's syndrome.
AQP4-IgG Dynamics and Exploratory Assessment of SERA-3 in Neuromyelitis Optica Spectrum Disorder Treated with Satralizumab.
Fingolimod Acutely Facilitates the Activation of TRKB in a BDNF-dependent Manner.
Lifetime exposure to shift work and risk of multiple sclerosis: retrospective and prospective cohort studies in UK Biobank.
Vasoactive intestinal Peptide as a diagnostic or prognostic biomarker in multiple sclerosis: A systematic review.
ZnO nanoparticles alleviate salinity stress through transcriptional and antioxidant regulation in chickpea.
Pages
« first
‹ previous
…
989
990
991
992
993
994
995
996
997
…
next ›
last »